GSA CAPITAL PARTNERS LLP - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 182 filers reported holding ACORDA THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$346,000
+765.0%
672,158
+1145.6%
0.06%
+163.6%
Q2 2020$40,000
-82.8%
53,961
-78.4%
0.02%
-62.1%
Q1 2020$233,000
+348.1%
250,271
+1273.2%
0.06%
+728.6%
Q3 2019$52,000
-94.0%
18,225
-72.1%
0.01%
-92.0%
Q1 2019$869,000
-8.4%
65,415
+7.4%
0.09%
-19.3%
Q4 2018$949,000
-20.7%
60,9000.0%0.11%
+65.2%
Q3 2018$1,197,000
-39.7%
60,900
-27.4%
0.07%
-37.1%
Q1 2018$1,984,000
+266.7%
83,900
+267.0%
0.10%
+183.8%
Q3 2017$541,000
+16.8%
22,862
+3.2%
0.04%
+48.0%
Q3 2016$463,000
-13.0%
22,155
+6.2%
0.02%
-13.8%
Q2 2016$532,000
-59.7%
20,860
-58.2%
0.03%
-65.5%
Q1 2016$1,320,000
+52.2%
49,899
+146.3%
0.08%
+100.0%
Q4 2015$867,000
-46.7%
20,262
-67.0%
0.04%
-47.5%
Q3 2015$1,628,000
+173.2%
61,403
+243.6%
0.08%
+247.8%
Q2 2015$596,000
-48.4%
17,870
-48.5%
0.02%
-50.0%
Q1 2015$1,155,000
-33.7%
34,694
-18.6%
0.05%
-62.3%
Q4 2014$1,742,000
+52.1%
42,614
+26.1%
0.12%
+103.3%
Q3 2014$1,145,000
-6.5%
33,801
-6.9%
0.06%
+9.1%
Q2 2014$1,224,000
+114.4%
36,315
+140.9%
0.06%
+34.1%
Q1 2014$571,000
-37.4%
15,075
-51.8%
0.04%
-43.1%
Q4 2013$912,000
+73.1%
31,247
+103.3%
0.07%
+71.4%
Q3 2013$527,000
+18.7%
15,370
+14.2%
0.04%
-20.8%
Q2 2013$444,00013,4550.05%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 815,838$27,192,0003.30%
ARMISTICE CAPITAL, LLC 186,000$6,199,0002.23%
1492 Capital Management LLC 95,639$3,188,0002.02%
Partner Investment Management, L.P. 19,498$650,0000.91%
Tekla Capital Management LLC 680,862$22,693,0000.82%
PFM Health Sciences, LP 817,396$27,244,0000.69%
HighPoint Advisor Group LLC 11,829$394,0000.61%
ARBOR CAPITAL MANAGEMENT LLC 89,183$2,972,0000.56%
Pergamon Offshore Advisors, L.P. 15,950$532,0000.56%
Penn Capital Management Company, LLC 390,212$13,006,0000.54%
View complete list of ACORDA THERAPEUTICS INC shareholders